The U.S. rare disease diagnostics market was valued at USD 12,875.84 million in 2023 and is projected to grow from USD 14,047.46 million in 2024 to USD 28,567.83 million by 2032, registering a CAGR of 9.3%. This growth is driven by increasing prevalence of rare diseases, advancements in genomic technologies, growing awareness and adoption of early...